BRIEF published on 01/26/2026 at 10:10, 3 months 26 days ago SOFTSWISS Names Denis Romanovskiy as Chief AI Officer Technology Leadership AI Strategy SOFTSWISS Denis Romanovskiy Enterprise-grade AI Platform
BRIEF published on 01/26/2026 at 10:10, 3 months 26 days ago SOFTSWISS nomme Denis Romanovskiy directeur de l'IA Leadership Technologique SOFTSWISS Stratégie IA Denis Romanovskiy Plateforme D'IA De Niveau Entreprise
BRIEF published on 01/26/2026 at 09:59, 3 months 26 days ago PWO Group Implements Temporary Work Reduction at Oberkirch Site PWO Group Job Preservation Industrial Strategy Work Reduction Oberkirch
BRIEF published on 01/26/2026 at 09:59, 3 months 26 days ago Le groupe PWO met en œuvre une réduction temporaire du travail sur le site d'Oberkirch Groupe PWO Préservation De L'emploi Stratégie Industrielle Oberkirch Réduction Du Travail
BRIEF published on 01/26/2026 at 09:56, 3 months 26 days ago Franchissement de seuils par Goldman Sachs chez Nanobiotix Droits De Vote Franchissement De Seuils Goldman Sachs NANOBIOTIX Acquisition Hors Marché
BRIEF published on 01/26/2026 at 09:56, 3 months 26 days ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
BRIEF published on 01/26/2026 at 09:50, 3 months 26 days ago KPS Capital Partners Acquires Controlling Stake in Novacel Mergers & Acquisitions KPS Capital Partners Chargeurs Invest Surface Protection Novacel Acquisition
BRIEF published on 01/26/2026 at 09:50, 3 months 26 days ago KPS Capital Partners acquiert une participation majoritaire dans Novacel Fusions Et Acquisitions KPS Capital Partners Chargeurs Invest Protection De Surface Acquisition De Novacel
BRIEF published on 01/26/2026 at 09:10, 3 months 26 days ago BioNxt Advances Cladribine ODF for Multiple Sclerosis and Myasthenia Gravis Multiple Sclerosis Drug Delivery Cladribine ODF Myasthenia Gravis BioNxt
BRIEF published on 01/26/2026 at 09:10, 3 months 26 days ago BioNxt fait progresser la cladribine ODF pour la sclérose en plaques et la myasthénie grave Sclérose En Plaques Cladribine ODF Myasthénie Grave Administration De Médicaments BioNxt
Published on 05/21/2026 at 23:00, 6 hours ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 6 hours ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 6 hours 45 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 04:40, 19 minutes ago Xinhua Silk Road: Anhui launches innovation and entrepreneurship contest to attract global sci-tech talents
Published on 05/22/2026 at 03:05, 1 hour 54 minutes ago BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
Published on 05/22/2026 at 02:40, 2 hours 19 minutes ago ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 21:45, 7 hours 14 minutes ago Rendeavour becomes the African Continental Free Trade Area's inaugural implementation partner for African industrialisation and trade infrastructure
Published on 05/21/2026 at 20:10, 8 hours 49 minutes ago Ernst Russ AG Divests MV 'EF Emira' and Raises Full-Year 2026 Guidance
Published on 05/21/2026 at 17:45, 11 hours 15 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 11 hours 15 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 12 hours 24 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
